Company Filing History:
Years Active: 2003-2004
Title: Joel Burton Erickson: Innovator in Anti-Retroviral Research
Introduction
Joel Burton Erickson is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of anti-retroviral research, holding a total of 2 patents. His work focuses on developing methods and compositions that inhibit membrane fusion-associated events, particularly in relation to HIV transmission.
Latest Patents
Erickson's latest patents include innovative approaches to combat HIV and respiratory syncytial virus (RSV). The first patent, titled "Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission," describes peptides that exhibit potent anti-retroviral activity. These peptides include DP178, which corresponds to amino acids 638 to 673 of the HIV-1 gp41 protein. The invention emphasizes the use of these peptides to inhibit the transmission of HIV to uninfected cells.
The second patent, "Methods and compositions for inhibition of membrane fusion-associated events including RSV transmission," also focuses on peptides derived from viral fusion proteins. This patent highlights peptides known as DP107 and DP178, which correspond to sequences found in the HR1 and HR2 regions of the HIV-1 gp41 protein. The invention further explores "DP107-like" and "DP178-like" peptides derived from other proteins, including those from the respiratory syncytial virus fusion protein.
Career Highlights
Erickson's career is marked by his dedication to advancing anti-retroviral therapies. His work at Trimeris, Inc. has positioned him as a key figure in the development of innovative solutions to combat viral infections. His research has the potential to significantly impact public health by providing new avenues for treatment.
Collaborations
Throughout his career, Erickson has collaborated with esteemed colleagues, including Peter W Jeffs and John William Lackey. These partnerships have fostered a collaborative environment that enhances the research and development of anti-retroviral therapies.
Conclusion
Joel Burton Erickson is a prominent inventor whose work in anti-retroviral research has led to significant advancements in the field. His patents reflect a commitment to developing effective methods for inhibiting viral transmission, particularly in the context of HIV and RSV. His contributions continue to pave the way for innovative treatments that can improve health outcomes for many individuals.